GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 52 filers reported holding GALERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $185,059 | -95.8% | 1,056,877 | -26.0% | 0.00% | – |
| Q2 2023 | $4,458,436 | +63.3% | 1,428,986 | +34.0% | 0.00% | – |
| Q1 2023 | $2,729,930 | +252.9% | 1,066,379 | +105.4% | 0.00% | – |
| Q4 2022 | $773,656 | +2.5% | 519,232 | +19.6% | 0.00% | – |
| Q3 2022 | $755,000 | +33.2% | 433,996 | -0.5% | 0.00% | – |
| Q2 2022 | $567,000 | -45.5% | 435,974 | -0.3% | 0.00% | – |
| Q1 2022 | $1,041,000 | -51.6% | 437,383 | -6.7% | 0.00% | – |
| Q4 2021 | $2,152,000 | -44.8% | 468,899 | -2.6% | 0.00% | – |
| Q3 2021 | $3,901,000 | -17.6% | 481,524 | 0.0% | 0.00% | – |
| Q2 2021 | $4,734,000 | +6.0% | 481,524 | -4.9% | 0.00% | – |
| Q1 2021 | $4,468,000 | -13.0% | 506,537 | +0.9% | 0.00% | – |
| Q4 2020 | $5,135,000 | +54.6% | 501,882 | +36.6% | 0.00% | – |
| Q3 2020 | $3,322,000 | +26.2% | 367,516 | -0.3% | 0.00% | – |
| Q2 2020 | $2,633,000 | +72.9% | 368,696 | +130.0% | 0.00% | – |
| Q1 2020 | $1,523,000 | +52.8% | 160,322 | +111.7% | 0.00% | – |
| Q4 2019 | $997,000 | – | 75,741 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 613,223 | $2,815,000 | 0.83% |
| Sofinnova Investments, Inc. | 3,083,712 | $14,154,000 | 0.83% |
| Novo Holdings A/S | 2,459,021 | $11,287,000 | 0.53% |
| ACUTA CAPITAL PARTNERS, LLC | 262,500 | $1,205,000 | 0.51% |
| Tekla Capital Management LLC | 898,374 | $4,124,000 | 0.13% |
| Aristides Capital LLC | 20,000 | $92,000 | 0.04% |
| XTX Topco Ltd | 13,499 | $62,000 | 0.04% |
| Blackstone Inc. | 1,678,984 | $7,707,000 | 0.02% |
| Taylor Wealth Management Partners | 11,635 | $53,000 | 0.02% |
| Belvedere Trading LLC | 96,486 | $255,000 | 0.01% |